The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
Open accessAbstract
Tumor and inflammation have many common features. One hallmark of both is enhanced vascular permeability, which is mediated by various factors including bradykinin, nitric oxide (NO), peroxynitrite, prostaglandins etc. A unique characteristic of tumors, however, is defective vascular anatomy. The enhanced vascular permeability in tumors is also distinctive in that extravasated macromolecules are not readily cleared. We utilized the enhanced permeability and retention (EPR) effect of tumors for tumor selective delivery of macromolecular drugs. Consequently, such drugs, nanoparticles or lipid particles, when injected intravenously, selectively accumulate in tumor tissues and remain there for long periods. The EPR effect of tumor tissue is frequently inhomogeneous and the heterogeneity of the EPR effect may reduce the tumor delivery of macromolecular drugs. Therefore, we developed methods to augment the EPR effect without inducing adverse effects for instance raising the systemic blood pressure by infusing angiotensin II during arterial injection of SMANCS/Lipiodol. This method was validated in clinical setting. Further, benefits of utilization of NO-releasing agent such as nitroglycerin or angiotensin-converting enzyme (ACE) inhibitors were demonstrated. The EPR effect is thus now widely accepted as the most basic mechanism for tumor-selective targeting of macromolecular drugs, or so-called nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Self-citationTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Self-citationVascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Self-citationOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,341
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Self-citationMutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Self-citationMaeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Self-citationFeelisch, M., & Noack, E. A. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90493-6 · Cited by 888
Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., & Berse, B. (1994) · PubMed · Cited by 810
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Dvorak, H. F., Nagy, J. A., Dvorák, J., & Dvořàk, A. M. (1988) · PubMed Central · Cited by 679
Jw, M. (1994) · UCL Discovery (University College London) · Cited by 584
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Self-citationAkaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y. M., Dietzschold, B., & Maeda, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2448 · Cited by 496
Self-citationZhao, M., Yang, M., Li, X.-M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 484
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Self-citationOxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran Polymer-Conjugated SOD
Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., & Maeda, H. (1989) · Science · doi:10.1126/science.2543070 · Cited by 418
Self-citationKano, M. R., Bae, Y., Iwata, C., Morishita, Y., Yashiro, M., Oka, M., Fujii, T., Komuro, A., Kiyono, K., Kaminishi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611660104 · Cited by 410
Huang, S., Robinson, J. B., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 369
How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question
Fojo, T., & Grady, C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp177 · Cited by 349
Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Morinaga, T., Mochinaga, M., Hiraoka, T., & Yokoyama, I. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90028-7 · Cited by 342
Self-citationSeymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationAkaike, T., Ando, M., Oda, T., Doi, T., Ijiri, S., Araki, S., & Maeda, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114499 · Cited by 332
Self-citationIwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
Self-citation(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Self-citationMaeda, H., Ueda, M., Morinaga, T., & Matsumoto, T. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00382a012 · Cited by 225
Self-citationOkamoto, T., Akaike, T., Nagano, T., Miyajima, S., Suga, M., Ando, M., Ichimori, K., & Maeda, H. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0127 · Cited by 224
Self-citationFang, J. Q., Sawa, T., Akaike, T., Akuta, T., Sahoo, S. K., Greish, K. F., Hamada, A., & Maeda, H. (2003) · PubMed · Cited by 223
Self-citationMaeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221
Self-citationWu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Self-citationNitrative DNA damage in inflammation and its possible role in carcinogenesis
Sawa, T., & Ohshima, H. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.06.005 · Cited by 198
Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S., & Maeda, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81661-1 · Cited by 194
Self-citationFang, J., Akaike, T., & Maeda, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000012119.83734.4e · Cited by 191
Self-citationNiles, J. C., Wishnok, J. S., & Tannenbaum, S. R. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.11.001 · Cited by 187
Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe, N., Beppu, T., Shibahara, S., Ogawa, M., & Maeda, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690624 · Cited by 182
Self-citationMicrovascular architecture of experimental colon tumors in the rat.
Skinner, S. A., Tutton, P. J. M., & O’Brien, P. E. (1990) · PubMed · Cited by 180
Nagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Self-citationEnhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Seki, T., Fang, J., & Maeda, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01323.x · Cited by 179
Self-citationHypoxic mammalian cell radiosensitization by nitric oxide.
Mitchell, J. B., Wink, D. A., DeGraff, W., Gamson, J., Keefer, L. K., & Krishna, M. C. (1993) · PubMed · Cited by 173
Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth
Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., & Maeda, H. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8+<1598::aid-cncr3>3.0.co;2-a · Cited by 173
Self-citationYasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
Free Radicals in Viral Pathogenesis: Molecular Mechanisms Involving Superoxide and NO
Akaike, T., Suga, M., & Maeda, H. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44206 · Cited by 169
Self-citationInvolvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163
Self-citationEnhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases
Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., & Maeda, H. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01114.x · Cited by 161
Self-citationMAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 159
Self-citationUmezawa, K., Akaike, T., Fujii, S., Suga, M., Setoguchi, K., Ozawa, A., & Maeda, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2932-2940.1997 · Cited by 155
Self-citationKimura, N. T., Taniguchi, S., Aoki, K., & Baba, T. (1980) · PubMed · Cited by 153
Microvascular corrosion casting in the study of tumor vascularity: a review.
Konerding, M. A., Miodoński, A. J., & Lametschwandtner, A. (1995) · PubMed · Cited by 144
Maki, S., Konno, T., & Maeda, H. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<751::aid-cncr2820560409>3.0.co;2-y · Cited by 142
Self-citationSahoo, S. K., Sawa, T., Fang, J. Q., Tanaka, S., Miyamoto, Y., Akaike, T., & Maeda, H. (2002) · Bioconjugate Chemistry · doi:10.1021/bc020010k · Cited by 138
Self-citationMatsumoto, K., Yamamoto, T., Kamata, R., & Maeda, H. (1984) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134892 · Cited by 133
Self-citationMaeda, H., Matsumura, Y., & Kato, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37555-0 · Cited by 130
Self-citationRole of Microbial Proteases in Pathogenesis
Maeda, H. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01129.x · Cited by 127
Self-citationKuwahara, H., Kanazawa, A., Wakamatu, D., et al. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf040045+ · Cited by 123
Yasuda, H., Nakayama, K., Watanabe, M., Suzuki, S., Fuji, H., Okinaga, S., Kanda, A., Zayasu, K., Sasaki, T., Asada, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1124 · Cited by 120
Jordan, B. F., Misson, P., Demeure, R., Baudelet, C., Beghein, N., & Gallez, B. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00694-5 · Cited by 107
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., & Maeda, H. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01910.x · Cited by 103
Self-citationOxygen Free Radicals as Pathogenic Molecules in Viral Diseases
Maeda, H., & Akaike, T. (1991) · Experimental Biology and Medicine · doi:10.3181/00379727-198-43309c · Cited by 102
Self-citationKamata, R., Yamamoto, T., Matsumoto, K., & Maeda, H. (1985) · Infection and Immunity · doi:10.1128/iai.48.3.747-753.1985 · Cited by 102
Self-citationSiemens, D. R., Heaton, J. P. W., Adams, M. A., Kawakami, J., & Graham, C. H. (2009) · Urology · doi:10.1016/j.urology.2009.03.004 · Cited by 100
Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Self-citationThe Chemical Properties of Nitric Oxide and Related Nitrogen Oxides
Fukuto, J. M., Cho, J. Y., & Switzer, C. H. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50003-4 · Cited by 95
Viral mutation accelerated by nitric oxide production during infection in vivo
Akaike, T., Fujii, S., Kato, A., Yoshitake, J., Miyamoto, Y., Sawa, T., Okamoto, S., Suga, M., Asakawa, M., Nagai, Y., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1447 · Cited by 95
Self-citationTargeted Therapy for Advanced Colorectal Cancer — More Is Not Always Better
Mayer, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejme0809343 · Cited by 89
Fang, J. Q., Qin, H., Nakamura, H., Tsukigawa, K., Shin, T., & Maeda, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02178.x · Cited by 88
Self-citationKallikrein–kinin in infection and cancer
Maeda, H., Wu, J., Okamoto, T., Maruo, K., & Akaike, T. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00104-6 · Cited by 83
Self-citationBradykinin and nitric oxide in infectious disease and cancer
Maeda, H., Akaike, T., Wu, J., Noguchi, Y., & Sakata, Y. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00063-x · Cited by 70
Self-citationMaeda, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.002 · Cited by 64
Self-citationNitric Oxide as an Endogenous Mutagen for Sendai Virus without Antiviral Activity
Yoshitake, J., Akaike, T., Akuta, T., Tamura, F., Ogura, T., Esumi, H., & Maeda, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8709-8719.2004 · Cited by 62
Self-citationHori, K., Suzuki, M., Tanda, S., Saito, S., Shinozaki, M., & Zhang, Q. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01797.x · Cited by 60
Tanaka, S., Akaike, T., Wu, J., Fang, J. Q., Sawa, T., Ogawa, M., Beppu, T., & Maeda, H. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086072 · Cited by 59
Self-citationDaruwalla, J., Nikfarjam, M., Greish, K. F., Malcontenti‐Wilson, C., Muralidharan, V., Christophi, C., & Maeda, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01619.x · Cited by 54
Self-citationMaruo, K., Akaike, T., Inada, Y., Ohkubo, I., Ono, T., & Maeda, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46762-7 · Cited by 48
Self-citationTumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
Iwai, K., Maeda, H., Konno, T., Matsumura, Y., Yamashita, R., Yamasaki, K., Hirayama, S., & Miyauchi, Y. (1987) · PubMed · Cited by 46
Self-citationHori, K., Saito, S., Takahashi, H., Sato, H., Maeda, H., & Sato, Y. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00940.x · Cited by 45
Self-citationDaruwalla, J., Greish, K. F., Malcontenti‐Wilson, C., Muralidharan, V., Iyer, A. K., Maeda, H., & Christophi, C. (2008) · Journal of Vascular Research · doi:10.1159/000165380 · Cited by 43
Self-citationFree radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH
Maeda, H., Sawa, T., Yubisui, T., & Akaike, T. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00139-1 · Cited by 43
Self-citationNoguchi, A., Takahashi, T., Yamaguchi, T., Kitamura, K., Noguchi, A., Tsurumi, H., Takashina, K., & Maeda, H. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb00093.x · Cited by 32
Self-citationTakeshita, J., Maeda, H., & Kanamaru, R. (1982) · PubMed · Cited by 31
Self-citationTumor-targeting amino acid auxotrophic Salmonella typhimurium
Hoffman, R. M. (2009) · Amino Acids · doi:10.1007/s00726-009-0261-8 · Cited by 31
Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin
Maeda, H., Takeshita, J., & Yamashita, A. (1980) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(80)90215-7 · Cited by 30
Self-citationPathophysiological Effects of High-Output Production of Nitric Oxide
Akaike, T., & Maeda, H. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50047-2 · Cited by 30
Self-citationWelcome clinical leadership at NICE
Lancet, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61249-0 · Cited by 16
Therapeutic Applications of Nitric Oxide for Malignant Tumor in Animal Models and Human Studies
Yasuda, H., Yanagihara, K., Nakayama, K., Mio, T., Sasaki, T., Asada, M., Yamaya, M., & Fukushima, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_22 · Cited by 13
Kuwahara, H., Kariu, T., Fang, J. Q., et al. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00089.x · Cited by 13
Yasuda, H., Nakayama, K., Watanabe, M., Suzuki, S., Kaneta, T., Asada, M., Takai, Y., Okinaga, S., Kanda, A., Yanagihara, K., et al. (2006) · Clinical Cancer Research · Cited by 9
(1989) · PubMed
Cited by
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Self-citationMaeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Self-citationNanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Metadata
- Authors
- MAEDA, H.
- Venue
- Proceedings of the Japan Academy, Series B
- Publisher
- Japan Academy
- Published
- 2012
- Volume
- 88
- Issue
- 3
- Pages
- 53-71
- ISSN
- 0386-2208 (ISSN-L)
- 1349-2896
- OpenAlex
- W1981147276
- Cited by
- 291
- References
- 98
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.